What 6 Analyst Ratings Have To Say About 89bio
Portfolio Pulse from Benzinga Insights
In the last quarter, 6 analysts have provided ratings for 89bio (NASDAQ:ETNB), with 2 being bullish and 4 somewhat bullish. The company has an average 12-month price target of $37.5, with a high of $49.00 and a low of $30.00. The average price target has increased by 10.29% over the past month.
July 03, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
89bio (NASDAQ:ETNB) received positive ratings from 6 analysts in the last quarter, with an average 12-month price target of $37.5. This target has increased by 10.29% over the past month.
The positive ratings and the increase in the average price target over the past month indicate a positive sentiment among analysts towards 89bio. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100